Dose and schedule of oral retinoic acid and indomethacin needed to effectively inhibit phorbol ester-induced epidermal ornithine decarboxylase activity

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1589-1592
Number of pages4
JournalCarcinogenesis
Volume6
Issue number11
StatePublished - 1985
Externally publishedYes

Fingerprint

Phorbols
Drug Dose Response Relationship
Drug Administration Schedule
Inbred Strains Mice
Ornithine Decarboxylase
Phorbol Esters
Skin Neoplasms
Tetradecanoylphorbol Acetate
Tretinoin
Indomethacin
Oral Administration
Appointments and Schedules
Skin
Poisons
Biosynthetic Pathways
Chemoprevention
Polyamines
Enzymes
Carcinogens
Neoplasms

ASJC Scopus subject areas

  • Cancer Research

Cite this

@article{f2ff985a21404848b214a2b451ab58a9,
title = "Dose and schedule of oral retinoic acid and indomethacin needed to effectively inhibit phorbol ester-induced epidermal ornithine decarboxylase activity",
author = "Loprinzi, {Charles Lawrence} and Verma, {A. K.}",
year = "1985",
language = "English (US)",
volume = "6",
pages = "1589--1592",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Dose and schedule of oral retinoic acid and indomethacin needed to effectively inhibit phorbol ester-induced epidermal ornithine decarboxylase activity

AU - Loprinzi, Charles Lawrence

AU - Verma, A. K.

PY - 1985

Y1 - 1985

UR - http://www.scopus.com/inward/record.url?scp=0022195383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022195383&partnerID=8YFLogxK

M3 - Article

C2 - 4053280

AN - SCOPUS:0022195383

VL - 6

SP - 1589

EP - 1592

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 11

ER -